top of page
ABOUT US
NEXJENNER
NEXJENNER Co., Ltd. is a
Pharmaceutical Development Innovation Cluster
Pharmaceutical Development Service Company based on the Long Experience and Know-How of Experts in the Formulation and Formulation Fields.
Nexjenner Co., Ltd. is a pharmaceutical development service company based on the
long experience and know-how of experts in the formulation and formulation fields.
In particular, from drug design (DD) to BGMP Active Pharmaceutical Ingredient production, physicochemical analysis, gene level toxicity and efficacy analysis, toxicity and efficacy analysis
in cells and animals, Drug Delivery System (DDS) development and formulation development, approval agencies (Ministry of Food and Drug Safety, FDA, etc.) We provide technology development services throughout the entire pharmaceutical development cycle, from drug design to licensing, including preparation of documentation (DMF, CTD) to be submitted to.
Full-Cycle Service Support to Develop Premium Vaccines & Biopharmacy
Oligonucleotide synthesis, LNP (Lipid Nanoparticles) and Liposome formulation technologies
In addition, we support customized drug delivery system technology by possessing Oligonucleotide synthesis, LNP (Lipid Nanoparticles), and Liposome formulation technologies to efficiently deliver drugs to target cells, tissues, and organs.
In particular, in order to penetrate the blood-brain barrier (BBB), which is a difficult problem in the development of treatments for brain diseases, a customized drug delivery system capable of efficient blood-brain barrier penetration is developed based on the analysis of the structure
and physicochemical properties of new drug substances. We provide design and formulation development services.
Nexjenner Co., Ltd. will provide differentiated services that can practically meet the demand for innovation with abundant infrastructure and experience, and will establish itself as a company
that customers can trust based on communication and speed. Additionally, we will work with our partners to expand an environment for win-win cooperation and shared growth.
bottom of page